文献速递颈动脉与弓上血管

19,000例颈动脉干预手术风险的国际行政数据分析

Procedural Risks of Carotid Intervention in 19,000 Patients.
PubMed 文献 · Ann Vasc Surg · 2020-06-26

该回顾性研究基于7国28家医院18,997例颈动脉干预患者,发现症状性患者CEA和CAS术后死亡及住院延长风险均高于无症状患者,其中症状性CAS死亡风险最高(3.3%)。行政数据集可提供当代手术风险的可靠估计。

要点

  • 症状性CEA死亡0.2%,无症状0.1%;症状性CAS死亡3.3%,无症状0.7%。
  • 症状性患者CAS死亡风险显著高于CEA,可能与病例选择偏倚相关。
  • 行政数据集能提供当代颈动脉干预手术风险的可靠估计。

核心结论

  • 症状性患者CEA和CAS术后死亡及住院延长风险均高于无症状患者。
  • 症状性CAS患者死亡风险尤其增高,部分归因于合并症较多的患者优先接受CAS。

研究设计与样本

  • 回顾性研究,纳入2011至2015年间7国28家医院18,997例颈动脉干预患者。
  • CEA组16,220例,CAS组2,777例,包含症状性和无症状性患者。

主要发现

  • 症状性CEA死亡率0.2%[5/2,118](95%CI 0.1-0.5),住院超2天比例57.0%[628/1,101](54.1-60.0)。
  • 无症状CEA死亡率0.1%[21/14,102](95%CI 0.1-0.2),住院超2天比例28.5%[2,864/10,039](27.7-29.4)。
  • 症状性CAS死亡率3.3%[10/307](95%CI 1.3-5.2),住院超2天比例64.3%[144/224](58.0-70.5)。
  • 无症状CAS死亡率0.7%[18/2,470](95%CI 0.4-1.1),住院超2天比例27.5%[601/2,187](25.6-29.4)。
  • CEA后症状性患者8.1%[89/1,101](95%CI 6.5-9.7)接受脑影像,无症状2.1%[207/10,039](1.8-2.3);CAS后症状性7.1%[16/224](4.0-10.7),无症状3.2%[71/2,187](2.5-4.0)。

临床怎么用

  • 应重视症状性颈动脉狭窄患者围手术期风险,尤其CAS术后死亡风险较高。
  • 行政数据集可用于监测和评估当代颈动脉干预的真实世界手术风险。

局限性

  • 为回顾性研究,可能受病例选择偏倚影响,如合并症较多的患者优先接受CAS。
  • 手术卒中未可靠记录,以脑影像检查作为替代指标。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Randomized controlled trials (RCTs) show that carotid endarterectomy (CEA) and carotid stenting (CAS) reduce long-term stroke risk in symptomatic and asymptomatic patients with carotid artery stenosis. Historical RCTs may not represent contemporary practice and administrative datasets may estimate procedural risks more reliably. We studied procedural risks after carotid intervention in a novel, international administrative data set of 18,997 patients admitted to 28 hospitals across 7 countries. METHODS: Symptomatic and asymptomatic patients undergoing CEA (n = 16,220) and CAS (n = 2,777) between 2011 and 2015 were studied retrospectively. The primary outcome was in-hospital death within seven days. The secondary outcome was the proportion of patients whose length of hospital stay (LOS) exceeded 2 days. We also describe the rate of computerized tomography brain imaging within 2 days of CEA and CAS (proxy for stroke) as procedural strokes were not reliably recorded. RESULTS: In symptomatic patients after CEA, mortality was 0.2% [5/2,118] (95% confidence interval: 0.1-0.5), and 57.0% [628/1,101] (54.1-60.0) had prolonged LOS. In asymptomatic patients after CEA, mortality was 0.1% [21/14,102] (0.1-0.2), and 28.5% [2,864/10,039] (27.7-29.4) had prolonged LOS. In symptomatic patients after CAS, mortality was 3.3% [10/307] (1.3-5.2), and 64.3% [144/224] (58.0-70.5) had prolonged LOS. In asymptomatic patients after CAS, mortality was 0.7% [18/2,470] (0.4-1.1), and 27.5% [601/2,187] (25.6-29.4) had prolonged LOS. After CEA, 8.1% [89/1,101] (6.5-9.7) symptomatic patients and 2.1% [207/10,039] (1.8-2.3) asymptomatic patients underwent brain imaging. After CAS, 7.1% [16/224] (4.0-10.7) symptomatic patients and 3.2% [71/2,187] (2.5-4.0) asymptomatic patients underwent brain imaging. CONCLUSIONS: Death and LOS after CEA and CAS were higher in symptomatic than asymptomatic patients. Symptomatic patients undergoing CAS had particularly increased risk of death. This may be partly explained by case selection, with more comorbid patients preferentially undergoing CAS. While RCTs effectively compare long-term efficacy of CEA versus CAS, administrative datasets can provide reliable estimates of contemporary procedural risks.

来源:Ann Vasc Surg,查看原文。版权归原作者所有。

引用

  1. Gaba KA, Halliday A, Bulbulia R, et al. Procedural Risks of Carotid Intervention in 19,000 Patients. Ann Vasc Surg. 2020. PMID: 32599106. doi:10.1016/j.avsg.2020.06.030

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。